Lord, Abbett & Co. LLC Argenx Se Transaction History
Lord, Abbett & Co. LLC
- $31.4 Billion
- Q3 2024
A detailed history of Lord, Abbett & Co. LLC transactions in Argenx Se stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 162,963 shares of ARGX stock, worth $102 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
162,963
Previous 162,963
-0.0%
Holding current value
$102 Million
Previous $88.3 Million
-0.0%
% of portfolio
0.28%
Previous 0.29%
Shares
25 transactions
Others Institutions Holding ARGX
# of Institutions
400Shares Held
30.9MCall Options Held
376KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.63 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.51MShares$2.19 Billion2.99% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.55 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$1.06 Billion0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$773 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $34.5B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...